Get the Daily Brief
Latest Biotech News
Bar-Ilan University and Sheba Medical Center Launch $120M Biotech Innovation Institute
Bar-Ilan University and Sheba Medical Center have established a joint research institute with a $120 million investment, located in Israel’s Health Tech Valley in Ramat Gan. This collaboration...
Lila Sciences Raises $235M Series A to Automate Drug Discovery with AI
Lila Sciences, a Flagship Pioneering-backed startup, secured $235 million in a Series A financing round to develop AI-based 'scientific superintelligence' platforms aimed at accelerating drug...
South Korea Speeds Biosimilar Approvals While Raising Application Fees
South Korea’s Ministry of Food and Drug Safety announced plans to significantly increase the application fees for biosimilar drug approvals starting in 2026, while simultaneously shortening review...
Biocartis Gets FDA Premarket Approval for Idylla MSI Companion Diagnostic
Biocartis secured FDA premarket approval for its Idylla CDx MSI Test, a rapid, automated assay to identify colorectal cancer patients with microsatellite instability-high (MSI-H) who may benefit...
aTyr Pharma Deflates After Lung Disease Trial Misses Endpoint
aTyr Pharma's experimental drug efzofitimod failed its Phase 3 trial in pulmonary sarcoidosis, missing the primary goal of significantly reducing steroid use compared to placebo. Despite some...
Novartis Doubles Down on Protein Degrader Deals with Monte Rosa
Novartis has expanded its collaboration with Monte Rosa Therapeutics, signing a new agreement with $120 million upfront and potential payments up to $5.7 billion. The deal secures Novartis...
Biocartis Secures FDA Approval for Rapid MSI Diagnostic in Colon Cancer
Biocartis received FDA premarket approval for its Idylla CDx MSI test designed to identify colorectal cancer patients with microsatellite instability-high tumors who may benefit from immunotherapy...
FDA Approves HPV Immunotherapy for Respiratory Papillomatosis
The FDA granted full approval to Precigen's Papzimeos, a non-replicating adenoviral vector immunotherapy targeting human papillomavirus (HPV) types 6 and 11 to treat recurrent respiratory...
Mount Sinai Launches AI-Driven Cardiac Catheterization Research Lab
Mount Sinai Fuster Heart Hospital inaugurated the Samuel Fineman Cardiac Catheterization Artificial Intelligence Research Lab, integrating AI technologies with cardiac catheterization procedures....
Lila Sciences Nears $235M Raise to Build AI-Driven Scientific Superintelligence
AI startup Lila Sciences is closing a $235 million Series A funding round to develop scientific superintelligence that integrates artificial intelligence deeply into laboratory research. The...
Helmholtz Munich and Parse Biosciences Forge Partnership to Map Lung Disease at Single-Cell Level
Helmholtz Munich and Parse Biosciences have initiated a strategic collaboration to create the world's largest lung disease perturbation atlas by profiling cellular responses to 900 pharmacological...
US Government Ends Funding for 22 mRNA Vaccine Research Projects
HHS Secretary Robert F. Kennedy Jr. has canceled $500 million in funding for 22 research grants developing mRNA vaccines for viruses such as SARS-CoV-2 and influenza. This decision reverses...
Novo Nordisk Plans 9,000 Layoffs amid Rising Competition in GLP-1 Market
Novo Nordisk announced plans to cut approximately 9,000 jobs (11.5% of its workforce) to strengthen commercial execution and focus resources on diabetes and obesity growth areas, especially its...
Quantum Technology Surpasses 3,000-Qubit Continuous Operation Milestone
Researchers unveiled a novel platform enabling coherent operation of a large-scale neutral atom quantum system with continuous manipulation of over 3,000 qubits. This represents a breakthrough in...
Novartis Doubles Down on Protein Degradation: $120M Deal with Monte Rosa
Novartis expanded its collaboration with Monte Rosa Therapeutics through a second deal worth $120 million upfront and potential total payments exceeding $5.7 billion. The agreement grants Novartis...
Limbus Medical Acquires Nostos Genomics to Enhance Genomics Software Portfolio
Limbus Medical Technologies has acquired German genomics company Nostos Genomics, known for its CE-IVD certified Aion genetic variant interpretation platform. The acquisition aims to complement...
Monte Rosa and Novartis Ink Broad Protein Degrader Collaboration
Monte Rosa Therapeutics and Novartis have deepened their partnership with a deal valued up to $5.7 billion, including a $120 million upfront payment. The collaboration focuses on developing novel...
AI Algorithm Predicts Cardiovascular Disease Risk From Routine Mammograms
A study published in Heart reveals a novel artificial intelligence algorithm can predict major cardiovascular disease risk in women using only routine mammographic images combined with age data....
Mount Sinai Launches AI Research Lab Focused on Cardiac Catheterization
Mount Sinai Fuster Heart Hospital has inaugurated The Samuel Fineman Cardiac Catheterization Artificial Intelligence Research Lab, aiming to enhance interventional cardiology through advanced AI...
Texas Biotech Ecosystem Spotlighted During BIO Visit
Texas’s biotech sector, employing over 129,000 people and generating $95 billion annually, was showcased during a visit by the Biotechnology Innovation Organization (BIO) led by CEO John F....